Company / Operating Margin
PALVELLA THERAPEUTICS, INC. Operating Margin History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-27.7%
FY2023
5-year range
-167.8% / -27.7%
FY2019-FY2023
Trend
+83.5%
vs FY2022
Sector context
#71 of 135
Health Care
What the data says
At -27.7%, PALVELLA THERAPEUTICS, INC.'s operating margin ranks #71 of 135 in the Health Care sector. Operating Margin returned to growth in FY2023 after 2 years of decline, reaching -27.7%.
Based on SEC 10-K filings.
-27.7% in FY2023 with a 5-year CAGR of +30.0%.
Improved from -115.7% to -27.7% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +31.0pp
- 5-Year Change
- +30.0pp
- 10-Year Change
- -
Sector benchmark
#71 of 135 in Health CareTop 53% of 135This company -27.7% Sector average -774.4%
▼
+96.4% above sector average
Key checks
Key Insights
- In FY2023, operating margin increased 83.5% year-over-year.
- Currently 746.7pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -27.7% | +83.5% |
| FY2022 | -167.8% | -45.1% |
| FY2021 | -115.7% | -97.1% |
| FY2020 | -58.7% | +0.0% |
| FY2019 | -58.7% | -1.6% |
| FY2018 | -57.7% | +85.2% |
| FY2017 | -390.3% | +0.0% |
| FY2016 | -390.3% | +16.4% |
| FY2015 | -466.6% | -247.8% |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 30, 2026